Why the study?
Does intravenous flecainide affect haemodynamic parameters and cardiac contractility in patients with coronary artery disease without cardiac failure?
Population
10 patients with coronary artery disease but without cardiac failure
Comparison
Intravenous flecainide (2 mg/kg) vs Baseline measurements immediately before…
Design
Case_series
Follow-up
10 minutes
Authors
Loading...
May caution IV flecainide use in CAD; case report leaves open need for controlled hemodynamic trials.
Does intravenous flecainide affect haemodynamic parameters and cardiac contractility in patients with coronary artery disease without cardiac failure?
Intravenous flecainide exerts a negative inotropic effect in patients with coronary artery disease, highlighting a potential risk of reduced cardiac performance.
Serruys et al. (1983) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: